Related references
Note: Only part of the references are listed.Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214
Bernard Escudier et al.
EUROPEAN UROLOGY (2020)
Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
Zedan Zhang et al.
CANCER CELL INTERNATIONAL (2020)
Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type
Qi Cai et al.
EBIOMEDICINE (2020)
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
T.K. Choueiri et al.
ANNALS OF ONCOLOGY (2020)
Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma
Xin Gao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers
Qing Kay Li et al.
SEMINARS IN CANCER BIOLOGY (2019)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data
Jiang-hui Zeng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions
Aly-Khan A. Lalani et al.
EUROPEAN UROLOGY (2019)
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial
A. Ari Hakimi et al.
CANCER DISCOVERY (2019)
Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery
Bradley C. Leibovich et al.
EUROPEAN UROLOGY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+T Cells With Expression of Exhaustion Markers
Laurence C. Menard et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inflammatory signaling cascades and autophagy in cancer
Teresa Monkkonen et al.
AUTOPHAGY (2018)
Identification of TWIST-interacting genes in prostate cancer
Peng Lyu et al.
SCIENCE CHINA-LIFE SCIENCES (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma
Nicolas A. Giraldo et al.
CLINICAL CANCER RESEARCH (2017)
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Stephane Chevrier et al.
CELL (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Senbabaoglu et al.
GENOME BIOLOGY (2016)
International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
Jenny J. Ko et al.
LANCET ONCOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Immune signature of tumor infiltrating immune cells in renal cancer
Katharina Geissler et al.
ONCOIMMUNOLOGY (2015)
Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma
Qiong Zou et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway
Rui Kang et al.
AUTOPHAGY (2012)
Inhibin/activin betaE-subunit in uterine endometrioid adenocarcinoma and endometrial cancer cell lines: From immunohistochemistry to clinical testing?
Ioannis Mylonas et al.
GYNECOLOGIC ONCOLOGY (2011)
Cistrome: an integrative platform for transcriptional regulation studies
Tao Liu et al.
GENOME BIOLOGY (2011)
Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Increase of Circulating CD4+CD25highFoxp3+ Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2
Annika Berntsen et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
Michael L. Nickerson et al.
CLINICAL CANCER RESEARCH (2008)
Cytokines and their relationship to the symptoms and outcome of cancer
Bostjan Seruga et al.
NATURE REVIEWS CANCER (2008)
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Bernard Escudier et al.
LANCET (2007)
Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor β signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model
L Xu et al.
CANCER RESEARCH (2005)
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: An International Multicenter Study
JJ Patard et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma - A stratification tool for prospective clinical trials
BC Leibovich et al.
CANCER (2003)
Improved prognostication of renal cell carcinoma using an integrated staging system
A Zisman et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
